CHRS vs PHM · rev $26.6M vs P/E 7.7, rev $7.39B
Coherus BioSciences Inc (CHRS) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
CHRS currently screens at market cap $223.7M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the CHRS and PHM stock pages for the full models.
Not investment advice.